Dr. Lal PathLabs Limited - ROE
LALPATHLAB.NS
Price:
$1898.9
Market Cap:
$317.07B
Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health assessment services, operating both domestically in India and across international borders. The company manages a comprehensive network of laboratories dedicated to conducting pathological investigations across various specialized fields. These include biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, in addition to other general pathological and radiological studies. Beyond its core testing operations, Dr. Lal PathLabs also offers laboratory staff training, technical support, and full-scale lab management services. As of March 31, 2022, its ...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2015-12-23
Stock Exchange
NSE
Ticker
LALPATHLAB.NS
PE Ratio
[56.15]
ROE
[21.99%]
Current Ratio
[0]
Dividend Yield
[0.84%]
Enterprise Value
[317.07B]
Dividend History
The ROE as of October 2026 (TTM) for Dr. Lal PathLabs Limited (LALPATHLAB.NS) is 21.99%
According to Dr. Lal PathLabs Limited’s latest financial reports and current stock price. The company's current ROE is 21.99%. This represents a change of 300.67% compared to the average of 5.49% of the last 4 quarters.
Dr. Lal PathLabs Limited (LALPATHLAB.NS) Historical ROE (quarterly & annually)
How has LALPATHLAB.NS ROE performed in the past?
The mean historical ROE of Dr. Lal PathLabs Limited over the last ten years is 21.05%. The current 21.99% ROE has changed 4.46% with respect to the historical average. Over the past ten years (40 quarters), LALPATHLAB.NS's ROE was at its highest in in the June 2021 quarter at 10.28%. The ROE was at its lowest in in the June 2020 quarter at 2.69%.
Average
21.05%
Median
21.73%
Minimum
14.33%
Maximum
23.43%
Dr. Lal PathLabs Limited (LALPATHLAB.NS) ROE by Quarter and Year
Discovering the peaks and valleys of Dr. Lal PathLabs Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 34.96%
Maximum Annual ROE = 23.43%
Minimum Annual Increase = -37.31%
Minimum Annual ROE = 14.33%
| Year | ROE | Change |
|---|---|---|
| 2026 | 20.13% | -10.24% |
| 2025 | 22.42% | 15.90% |
| 2024 | 19.34% | 34.96% |
| 2023 | 14.33% | -37.31% |
| 2022 | 22.86% | -2.39% |
| 2021 | 23.42% | 7.07% |
| 2020 | 21.88% | 3.85% |
| 2019 | 21.07% | -2.38% |
| 2018 | 21.58% | -7.90% |
| 2017 | 23.43% | -10.21% |
Dr. Lal PathLabs Limited (LALPATHLAB.NS) Average ROE
How has LALPATHLAB.NS ROE performed in the past?
The current ROE of Dr. Lal PathLabs Limited (LALPATHLAB.NS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
20.63%
5-year avg
19.82%
10-year avg
21.05%
Dr. Lal PathLabs Limited (LALPATHLAB.NS) ROE vs. Peers
How is LALPATHLAB.NS’s ROE compared to its peers?
Dr. Lal PathLabs Limited’s ROE is less than Metropolis Healthcare Limited (13.64%), less than Vijaya Diagnostic Centre Limited (20.58%), greater than Aspira Pathlab & Diagnostics Limited (-3.40%), less than Thyrocare Technologies Limited (31.48%), less than Dr. Lalchandani Labs Ltd. (0.52%), less than Suraksha Diagnostic Ltd. (15.10%), less than Nidan Laboratories & Healthcare Ltd. (0%),
| Company | ROE | Market cap |
|---|---|---|
| 13.64% | $109.03B | |
| 20.58% | $147.26B | |
| -3.40% | $1.16B | |
| 31.48% | $79.74B | |
| 0.52% | $27.95M | |
| 15.10% | $16.11B | |
| 0% | $187.65M |
Build a custom stock screener for Dr. Lal PathLabs Limited (LALPATHLAB.NS) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Dr. Lal PathLabs Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Dr. Lal PathLabs Limited (LALPATHLAB.NS) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Dr. Lal PathLabs Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Dr. Lal PathLabs Limited's ROE?
How is the ROE calculated for Dr. Lal PathLabs Limited (LALPATHLAB.NS)?
What is the highest ROE for Dr. Lal PathLabs Limited (LALPATHLAB.NS)?
What is the 3-year average ROE for Dr. Lal PathLabs Limited (LALPATHLAB.NS)?
What is the 5-year average ROE for Dr. Lal PathLabs Limited (LALPATHLAB.NS)?
How does the current ROE for Dr. Lal PathLabs Limited (LALPATHLAB.NS) compare to its historical average?